Cargando…
Barred from better medicine? Reexamining regulatory barriers to the inclusion of prisoners in research
In 2015, President Obama announced plans for the Precision Medicine Initiative(®) (PMI), an ambitious longitudinal project aimed at revolutionizing medicine. Integral to this Initiative is the recruitment of over one million Americans into a volunteer research cohort, the All of Us(SM) Research Prog...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570691/ https://www.ncbi.nlm.nih.gov/pubmed/28852561 http://dx.doi.org/10.1093/jlb/lsw064 |
_version_ | 1783259205167218688 |
---|---|
author | Huang, Elaine Cauley, Jacqueline Wagner, Jennifer K. |
author_facet | Huang, Elaine Cauley, Jacqueline Wagner, Jennifer K. |
author_sort | Huang, Elaine |
collection | PubMed |
description | In 2015, President Obama announced plans for the Precision Medicine Initiative(®) (PMI), an ambitious longitudinal project aimed at revolutionizing medicine. Integral to this Initiative is the recruitment of over one million Americans into a volunteer research cohort, the All of Us(SM) Research Program. The announcement has generated much excitement but absent is a discussion of how the All of Us Research Program—to be implemented within the context of social realities of mass incarcerations and racial disparities in criminal justice and healthcare—might excaberate health disparities. We examine how attainment of Initiative's stated goals of reflecting the diversity of the American population and including all who are interested in participating might be impeded by regulatory and administrative barriers to the involvement of participants who become incarcerated during longitudinal studies. Changes have been proposed to the federal policy for human subjects research protections, but current regulations and administrative policies—developed under a protectionist paradigm in response to scandalous research practices with confined populations—dramatically limit research involving prisoners. Our review provides rationale for the development of Initiative policies that anticipate recruitment and retention obstacles that might frustrate inclusivity and exacerbate health disparities. Furthermore, we question the effective ban on biomedical and behavioral research involving prisoners and advocate for regulatory reforms that restore participatory research rights of prisoners. Disparities in health and justice are intertwined, and without regulatory reforms to facilitate participatory research rights of prisoners and careful planning of viable and responsible recruitment, engagement, and retention strategies, Initiative could miss discovery opportunities, exacerbate health disparities, and increase levels of distrust in science. |
format | Online Article Text |
id | pubmed-5570691 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-55706912017-08-29 Barred from better medicine? Reexamining regulatory barriers to the inclusion of prisoners in research Huang, Elaine Cauley, Jacqueline Wagner, Jennifer K. J Law Biosci Original Article In 2015, President Obama announced plans for the Precision Medicine Initiative(®) (PMI), an ambitious longitudinal project aimed at revolutionizing medicine. Integral to this Initiative is the recruitment of over one million Americans into a volunteer research cohort, the All of Us(SM) Research Program. The announcement has generated much excitement but absent is a discussion of how the All of Us Research Program—to be implemented within the context of social realities of mass incarcerations and racial disparities in criminal justice and healthcare—might excaberate health disparities. We examine how attainment of Initiative's stated goals of reflecting the diversity of the American population and including all who are interested in participating might be impeded by regulatory and administrative barriers to the involvement of participants who become incarcerated during longitudinal studies. Changes have been proposed to the federal policy for human subjects research protections, but current regulations and administrative policies—developed under a protectionist paradigm in response to scandalous research practices with confined populations—dramatically limit research involving prisoners. Our review provides rationale for the development of Initiative policies that anticipate recruitment and retention obstacles that might frustrate inclusivity and exacerbate health disparities. Furthermore, we question the effective ban on biomedical and behavioral research involving prisoners and advocate for regulatory reforms that restore participatory research rights of prisoners. Disparities in health and justice are intertwined, and without regulatory reforms to facilitate participatory research rights of prisoners and careful planning of viable and responsible recruitment, engagement, and retention strategies, Initiative could miss discovery opportunities, exacerbate health disparities, and increase levels of distrust in science. Oxford University Press 2017-01-10 /pmc/articles/PMC5570691/ /pubmed/28852561 http://dx.doi.org/10.1093/jlb/lsw064 Text en © The Author 2017. Published by Oxford University Press on behalf of Duke University School of Law, Harvard Law School, Oxford University Press, and Stanford Law School. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Article Huang, Elaine Cauley, Jacqueline Wagner, Jennifer K. Barred from better medicine? Reexamining regulatory barriers to the inclusion of prisoners in research |
title | Barred from better medicine? Reexamining regulatory barriers to the inclusion of prisoners in research |
title_full | Barred from better medicine? Reexamining regulatory barriers to the inclusion of prisoners in research |
title_fullStr | Barred from better medicine? Reexamining regulatory barriers to the inclusion of prisoners in research |
title_full_unstemmed | Barred from better medicine? Reexamining regulatory barriers to the inclusion of prisoners in research |
title_short | Barred from better medicine? Reexamining regulatory barriers to the inclusion of prisoners in research |
title_sort | barred from better medicine? reexamining regulatory barriers to the inclusion of prisoners in research |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570691/ https://www.ncbi.nlm.nih.gov/pubmed/28852561 http://dx.doi.org/10.1093/jlb/lsw064 |
work_keys_str_mv | AT huangelaine barredfrombettermedicinereexaminingregulatorybarrierstotheinclusionofprisonersinresearch AT cauleyjacqueline barredfrombettermedicinereexaminingregulatorybarrierstotheinclusionofprisonersinresearch AT wagnerjenniferk barredfrombettermedicinereexaminingregulatorybarrierstotheinclusionofprisonersinresearch |